Biocardia logo

Biocardia Share Price Today

(NASDAQ: BCDA)

Biocardia share price is $2.57 & ₹223.83 as on 5 Feb 2025, 2.30 'hrs' IST

$2.57

0.16

(6.64%)

Market is closed - opens 8 PM, 05 Feb 2025

View live Biocardia share price in Dollar and Rupees. Guide to invest in Biocardia stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Biocardia, along with analyst recommendations, forecasts, and comprehensive financials.

Biocardia share price movements

  • Today's Low: $2.36
    Today's High: $2.62

    Day's Volatility :9.81%

  • 52 Weeks Low: $1.63
    52 Weeks High: $8.85

    52 Weeks Volatility :81.64%

Biocardia (BCDA) Returns

PeriodBiocardia IncIndex (Russel 2000)
3 Months
0.42%
0.0%
6 Months
-15.44%
0.0%
1 Year
-65.45%
0.0%
3 Years
-92.35%
-11.7%

Biocardia (BCDA) Key Statistics

in dollars & INR

Previous Close
$2.41
Open
$2.36
Today's High
$2.6167
Today's Low
$2.36
Market Capitalization
$11.3M
Today's Volume
$41.3K
52 Week High
$8.85
52 Week Low
$1.625
Revenue TTM
$428.0K
EBITDA
$-8.5M
Earnings Per Share (EPS)
$-4.03
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-703.62%

How to invest in Biocardia Stock (BCDA) from India?

It is very easy for Indian residents to invest directly in Biocardia from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Biocardia stock in both Indian Rupees (INR) and US Dollars (USD). Search for Biocardia or BCDA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Biocardia or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Biocardia shares which would translate to 0.339 fractional shares of Biocardia as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Biocardia, in just a few clicks!

Returns in Biocardia (BCDA) for Indian investors in Rupees

The Biocardia stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Biocardia investment value today

Current value as on today

₹41,684

Returns

₹58,316

(-58.32%)

Returns from Biocardia Stock

₹63,181 (-63.18%)

Dollar Returns

₹4,865 (+4.86%)

Indian investors sentiment towards Biocardia (BCDA)

-27%

Period: Jan 5, 2025 to Feb 4, 2025. Change in 30 Days versus previous period

Search interest for Biocardia Stock from India on INDmoney has decreased by -27% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Biocardia

  • Susquehanna International Group, LLP

    1.54%

  • Geode Capital Management, LLC

    0.32%

  • Vanguard Group Inc

    0.28%

  • Tower Research Capital LLC

    0.03%

  • Pingora Partners LLC

    0.02%

  • Bank of America Corp

    0.01%

Analyst Recommendation on Biocardia

Buy

    75%Buy

    25%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Biocardia(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
2
2
3
Sell
0
0
0

Analyst Forecast on Biocardia Stock (BCDA)

What analysts predicted

Upside of 503.11%

Target:

$15.50

Current:

$2.57

Insights on Biocardia Stock (Ticker Symbol: BCDA)

  • Price Movement

    In the last 7 days, BCDA stock has moved up by 5.7%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 55.0K → 3.0K (in $), with an average decrease of 94.6% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -1.64M → -1.73M (in $), with an average decrease of 5.5% per quarter
  • BCDA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 58.6% return, outperforming this stock by 121.0%
  • BCDA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 88.8% return, outperforming this stock by 180.6%
  • Price to Sales

    ForBCDA every $1 of sales, investors are willing to pay $9.1, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $16.6 for every $1 of sales.

Biocardia Technicals Summary

Sell

Neutral

Buy

Biocardia is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Biocardia (BCDA) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Biocardia Inc logo
0.42%
-15.44%
-65.45%
-92.35%
-96.59%
Biontech Se logo
-0.32%
51.19%
24.81%
-30.66%
288.02%
Regeneron Pharmaceuticals, Inc. logo
-6.9%
-37.55%
-28.89%
7.15%
74.63%
Vertex Pharmaceuticals Incorporated logo
16.87%
0.96%
13.03%
93.36%
95.94%
Alnylam Pharmaceuticals, Inc. logo
17.76%
5.53%
59.46%
84.7%
118.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Biocardia Inc logo
NA
NA
0.0
-3.52
-7.04
-1.16
NA
-1.02
Biontech Se logo
160.8
NA
0.04
-3.32
-0.02
-0.01
NA
79.73
Regeneron Pharmaceuticals, Inc. logo
16.64
16.64
1.08
44.92
0.17
0.07
NA
272.04
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.21
0.49
-0.03
0.12
NA
60.65
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
-0.18
-15.01
-0.03
NA
0.25
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Biocardia Inc logo
Buy
$11.3M
-96.59%
NA
0.0%
Biontech Se logo
Buy
$29.7B
288.02%
160.8
-15.36%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.0B
74.63%
16.64
33.61%
Vertex Pharmaceuticals Incorporated logo
Buy
$118.9B
95.94%
32.84
-4.51%
Alnylam Pharmaceuticals, Inc. logo
Buy
$35.0B
118.8%
NA
-15.86%

About Biocardia

BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States. Its lead product candidate is CardiAMP, an autologous mononuclear cell therapy system in Phase III clinical trial for the treatment of ischemic heart failure with reduced ejection fraction and refractory angina resulting from chronic myocardial ischemia. The company is also developing an allogeneic cells therapy platform, which is an investigational culture expanded bone marrow derived mesenchymal cell therapy in Phase I/II trial to treat ischemic heart failure and acute respiratory distress syndrome. In addition, it offers the Helix biotherapeutic delivery system for minimally invasive targeted delivery of biologic agents to the heart; and Morph deflectable guides and sheaths. The company has collaboration agreements with CellProthera in the development of ProtheraCytes, which is currently under Phase II trial for the treatment of acute myocardial infarction. BioCardia, Inc. is based in Sunnyvale, California.
Organization
Biocardia
Employees
16
CEO
Dr. Peter A. Altman Ph.D.
Industry
Biotechnology

Management People of Biocardia

NameTitle
Dr. Peter A. Altman Ph.D.
CEO, President & Director
Mr. David McClung
Chief Financial Officer
Mr. Edward M. Gillis
Senior Vice President of Devices

Important FAQs about investing in BCDA Stock from India :

What is Biocardia share price today?

Biocardia share price today stands at $2.57, Open: $2.36 ; Previous Close: $2.41 ; High: $2.62 ; Low: $2.36 ; 52 Week High: $8.85 ; 52 Week Low: $1.63.

The stock opens at $2.36, after a previous close of $2.41. The stock reached a daily high of $2.62 and a low of $2.36, with a 52-week high of $8.85 and a 52-week low of $1.63.

Can Indians buy Biocardia shares?

Yes, Indians can invest in the Biocardia (BCDA) from India.

With INDmoney, you can buy Biocardia at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Biocardia at zero transaction cost.

How can I buy Biocardia shares from India?

It is very easy to buy Biocardia from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Biocardia (BCDA) be purchased?

Yes, you can buy fractional shares of Biocardia with INDmoney app.

What are the documents required to start investing in Biocardia stocks?

To start investing in Biocardia, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Biocardia Stock (BCDA)?

Today’s highest price of Biocardia (BCDA) is $2.62.

Today’s lowest price of Biocardia (BCDA) is $2.36.

What is today's market capitalisation of Biocardia?

Today's market capitalisation of Biocardia BCDA is 11.3M

What is the 52 Week High and Low Range of Biocardia Stock (BCDA)?

  • 52 Week High

    $8.85

  • 52 Week Low

    $1.63

What are the historical returns of Biocardia (BCDA)?

  • 1 Month Returns

    0.42%

  • 3 Months Returns

    -15.44%

  • 1 Year Returns

    -65.45%

  • 5 Years Returns

    -96.59%

Who is the Chief Executive Officer (CEO) of Biocardia ?

Dr. Peter A. Altman Ph.D. is the current Chief Executive Officer (CEO) of Biocardia.